ArticleFrontiers in pharmacology2026
Dihydromyricetin confers protection against myocardial ischemia-reperfusion injury by inhibiting ferroptosis through direct targeting of PPARα.
Binwei Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.